In vivo toxicity of Nufs-DTX.
Notes: (A) All values of CBC count (WBCs, neutrophils, and platelets) of both the groups were within normal ranges. (B) All values of AST, ALT, BUN, and creatinine in both the groups were within normal ranges. (C) Kaplan–Meier plot (n=10), right panel shows changes in body weight (P<0.001, Student’s t-test between the Taxotere™ group and the Nufs-DTX group). While there was no event of death observed in the Nufs-DTX-treated group, only 20% survival rate was observed in the Taxotere™ 30 mg/kg group. A significant loss of body weight was observed in a Taxotere™-treated group. (D) Paw withdrawal latency time (n=5). Taxotere™ significantly increased thermal threshold (*P<0.05, Student’s t-test between the Taxotere™ group and the control group). (E) An electron microscopic analysis of neuropathological changes in the sciatic nerve after Nufs-DTX treatment. While there were no or minor myelin shape changes in the Nufs-DTX-treated group, collapsed or irregular axons and abnormally condensed myelin sheaths (white arrows) were observed in a Taxotere™-treated group. (F) DTX-induced edema (n=5). Accumulative injections of Taxotere™ induced paw edema. However, no changes were observed in the in Nufs-DTX-treated group (***P<0.001, Student’s t-test between the Taxotere™ group and the control group).
Abbreviations: ALN, alanine transaminase; AST, aspartate transaminase; BUN, blood urea nitrogen; CBC, complete blood count; DTX, docetaxel; Nufs, nanoparticulation using fat and supercritical fluid; WBCs, white blood cells.